Vivo Capital, LLC
Source: SEC Form 13F · as of Mar 2026Vivo Capital, LLC holds 20 biotech & pharma companies tracked by BioSniper, totaling $952.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$952.8M
| Company | Shares | Value |
|---|---|---|
| PRAXPraxis Precision Medicines, Inc. | 677,790 | $218.4M |
| TERNTerns Pharmaceuticals, Inc. | 2,668,836 | $140.7M |
| TNGXTango Therapeutics, Inc. | 4,309,560 | $90.2M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 707,996 | $59.4M |
| DYNDyne Therapeutics, Inc. | 3,114,932 | $56.5M |
| ABVXAbivax SA | 479,078 | $53.3M |
| ORICOric Pharmaceuticals, Inc. | 3,697,572 | $46.8M |
| AVBPArriVent BioPharma, Inc. | 1,771,832 | $40.9M |
| LBRXLB PHARMACEUTICALS INC | 1,600,000 | $39.5M |
| MANEVeradermics Incorporated | 600,000 | $37.9M |
| MLTXMoonLake Immunotherapeutics | 2,000,000 | $37.3M |
| COGTCogent Biosciences, Inc. | 844,600 | $32.5M |
| GERNGERON CORP | 17,343,594 | $25.8M |
| OLMAOlema Pharmaceuticals, Inc. | 1,343,686 | $20.0M |
| SLNOSOLENO THERAPEUTICS INC | 589,818 | $19.7M |
| SRZNSurrozen Inc. | 520,000 | $15.1M |
| MNPRMonopar Therapeutics | 181,000 | $9.9M |
| VRDNViridian Therapeutics, Inc.\DE | 332,576 | $6.5M |
| CMPSCOMPASS Pathways plc | 400,000 | $2.2M |
| DTILPRECISION BIOSCIENCES INC | 9,350 | $51K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.